Siren, L.L.C. Kymera Therapeutics, Inc. Transaction History
Siren, L.L.C.
- $2.26 Trillion
- Q4 2024
A detailed history of Siren, L.L.C. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 2,969,733 shares of KYMR stock, worth $110 Million. This represents 5.28% of its overall portfolio holdings.
Number of Shares
2,969,733
Previous 2,969,733
-0.0%
Holding current value
$110 Million
Previous $141 Billion
15.0%
% of portfolio
5.28%
Previous 7.03%
Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
184Shares Held
66MCall Options Held
44.5KPut Options Held
38.5K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$253 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$221 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$196 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$190 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$190 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.02B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...